期刊文献+

体外培养的平滑肌细胞多梳基因Bmi-1的表达变化及其与细胞增殖和细胞周期的关系 被引量:2

The Dynamic Expression of Polycomb Gene Bmi-1 in Cultured VSMC in Vitro and Its Correlation with Vascular Smooth Muscle Cell Proliferation and Cell Cycle
下载PDF
导出
摘要 目的探讨多梳基因Bmi-1在体外培养的血管平滑肌细胞中的表达变化及其与细胞增殖和细胞周期的关系,以了解在平滑肌细胞表型转换及增殖过程中的早期基因事件。方法逆转录聚合酶链反应检测1~4代大鼠平滑肌细胞及不同浓度的丙戊酸钠作用于第4代血管平滑肌细胞24、48、72和96 h后Bmi-1 mRNA的表达。倒置显微镜下观察正常细胞及各组药物作用后细胞数量和形态的变化。四甲基偶氮唑盐法分析各组药物作用后细胞增殖活力的改变。流式细胞术检测细胞周期和细胞凋亡。结果体外培养的第1代大鼠血管平滑肌细胞有少量的Bmi-1 mRNA的表达,在传代过程中Bmi-1 mRNA的表达量逐渐增加,到第4代达到较高水平;经0.5~4.0mmol/L丙戊酸钠作用于第4代平滑肌细胞24、48、72和96 h后,Bmi-1 mRNA的表达量随浓度的增加和时间的延长而呈下降趋势。各浓度丙戊酸钠干预组随作用时间及浓度的增大均出现了生长抑制。经丙戊酸钠处理后各组出现细胞周期G2/M期阻滞及细胞凋亡,且随药物浓度的升高而增大。结论平滑肌细胞体外增殖及由收缩表型向合成表型的转化过程中出现平行的Bmi-1基因表达上调。丙戊酸钠可通过降低Bmi-1的表达明显抑制血管平滑肌细胞生长,并具有细胞周期G2/M期阻滞及促凋亡作用。 Aim To investigate the relationship between the dynamic expression of polyeomb gene Bmi-1 in cultured vascular smooth muscle cell ( VSMC ) in vitro and the VSMC proliferation and cell cycle, so as to illustrate the potential early mechanism in VSMC proliferation and phenotype transition. Methods The Bmi-1 mRNA transcription in cultured VSMC in vitro from the first to fourth passage, and in the valproate acid sodium (VPA) -treated VSMC for 24, 48, 72 and 96 h were measured by RT-PCR. The morphological changes and the proliferation rate of VSMC were examined by invert microscope and methyl thiazolyl tetrazolium (MTT) assay. The apoptosis and cell cycle were analyzed by flow cytometry. Results The expression of Bmi-1 in first passage of cultured VSMC was mild, and then increased progressively along with the passage. The treatment of VSMC by VPA induced down-expression of Bmi-1 in a dose-dependent and time-dependent manner. The morphological examination and MTT assay in VPA-treated groups also disclosed significant inhibition in proliferation rate of VSMC. The analysis of flow cytometry revealed increased apoptosis rate and G2/M phase blockage in cell cycle of VSMC in a VPA dose-dependent manner. Conclusion The up-expression of Bmi-1 gene was parallel with the VSMC proliferation and phenotype transition in vitro. The histone deacetylase inhibitor VPA could induce down-expression of Bmi-1. It is suggested that the VPA could inhibit the VSMC proliferation by way of down-expression of polyeomb gene Bmi-1, block the cultured VSMC in G2/M phase and pro-apoptosis effect.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2009年第1期43-47,共5页 Chinese Journal of Arteriosclerosis
基金 高等学校博士学科点专项科研基金资助(20050610050)
关键词 BMI-1 丙戊酸钠 血管平滑肌细胞 细胞增殖 细胞周期 Bmi-1 Valproate Acid Sodium Vascular Smooth Muscle Cell Cell Proliferation Cell Cycle
  • 相关文献

参考文献14

  • 1Shanahan CM, Weissberg PL. Smooth muscle cell heterogeneity patterns of gene expression in vascular smooth muscle cells in vitro and in vivo [J]. Arterioscler Thromb Vasc Biol, 1998, 18 (3) : 333-338.
  • 2王生兰,苏娟,徐一洲,谢静,王树人.大鼠血管平滑肌细胞体外培养的表型转换及其鉴定[J].中国动脉硬化杂志,2008,16(4):268-272. 被引量:23
  • 3Park IK, Qian D, Kiel M, et al. Bmi-1 is required for maintenance of adult serf-renewing haematopoietic stem cells [ J ]. Nature, 2003, 423 ( 6937 ) : 302-305.
  • 4Park IK, Morrison SJ, Clarke MF. Bmi-1, stem cells, and senescence regulation [J]. J Clin Invest, 2004, 113 (2) : 175-179.
  • 5Takeda Y, Moil T, Imabayashi H, et al . Can the life span of human marrow stromal cells be prolonged by Bmi-1, E6, ET, and/or telomerase without affecting cardiomyogenic differentiation [ J ] ? J Gene Med, 2004, 6 (8) : 833-845.
  • 6Molofsky AV, Partial R, Iwashita T, et al. Bmi-1 dependence distinguishesneural stem cell self-renewal from progenitor proliferation [ J ]. Nature, 2003, 425 (6961): 962-967.
  • 7Moss TJ, Wallrath LL. Connections between epigenefie gene silencing and human disease [ J ]. Murat Res, 2007, 618 (1-2) : 163-174.
  • 8Marks PA, Rif kind RA, Richon VM, et al. Histone deacetylases and cancer: causes and therapies [J]. Nature, 2001, 1 (3) : 194-202.
  • 9Duenas-Gonzalez A, Candelaria M, Perez-Plascencia C, et al. Valproic acid as epigenetic cancer durg: preclinical, clinical and transcriptional effects on solid tumors [ J]. Cancer Treat Rev,2008, 34 (3) : 206-222.
  • 10Catalano MG, Fortunati N, Pugliese M, et al. Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxornhicin in anaplastic thyroid cancer cells [J]. J Endocrinol, 2006, 191 (2) : 465-472.

二级参考文献16

  • 1李玉光,许端敏,闫纯英,石永英,陈畅,卢成志.雷帕霉素对球囊损伤后血管平滑肌细胞表型及内膜增生的影响[J].中国动脉硬化杂志,2005,13(4):414-416. 被引量:8
  • 2Shanahan CM,Weissberg PL.Smooth muscle cell heterogeneity:pattems of gene expression in vascular smooth muscle cells in vitro and in vivo[J].Arterioscler Thromb Vasc Biol, 1998, 18 (3) : 333-338.
  • 3Majesky MW.Developmental basis of vascular smooth muscle biversity[J].Arterioscler Thromb Vasc Biol,2007, 27 (6) : 1248-258.
  • 4Owens G, Kumar M, Wamhoff B. Molecular regulation of vascular smooth muscle cell differentiation in development and disease[J]. Physiol Rev, 2004, 84 (3) : 767-801.
  • 5Fukuda Noboru Flu WY, Satoh Chikara, et al. Contribution of synthetic pheontype on the enhanced angiotensin Ⅱ-generating system in vascular smooth muscle cells from spontaneously hypertensive rats [J]. Hypertension, 1999, 17 (8): 1099-107.
  • 6Hu WY,Fukuda Noboru,Kanmatsuse Katsuo.Growth Characteristics,angiotensin Ⅱ generation,and microarray-determinede gene expression in vascular smooth muscle cells from young spontaneously hypertensive rats[J].Hypertension, 2002, 20 (7): 1323-333.
  • 7Thyherg J. Caveolae and cholesterol distribution in vascular smooth muscle cells of different phenotypes[J].J Histochem Cytochem, 50 (2) : 185-195.
  • 8袁中华 杨永宗 杨小毅 等.氧化低密度脂蛋白诱导血管平滑肌细胞凋亡的泡沫化.中国病理生理杂志,2000,16(10):986-987.
  • 9Dusserre E, Bourdillon MC, Pulcinl T, et al. Decmase in high density lipopro rein binding sites is associated with decrease in intracellular cholesterol efflux in dedifferentiated aortic smooth muscle cells [ J ]. Biochim Biophys Acta, 1994, 1212 (2) : 235-244.
  • 10Rensen SS, Doevendans PA, Van Eys GJ. Regulation and eharaeteristics of vascular smooth muscle cell phenotypic diversity [ J ]. Netherlands Heart J, 2007, 15 (3): 100-108.

共引文献22

同被引文献27

  • 1Zaina S,Dossing KB,Lindholm MW,et al.Chromatin modification by lipids and lipoprotein components:an initiating event in atherogenesis?[J].Curr Opin Lipidol,2005,16(5):549-553.
  • 2Lipskaia L,Pourci M-L,Delomenie C,et al.Phosphoinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation[J].Circ Res,2003,92(10):1115-1122.
  • 3Goldstein JL,Brown MS.Regulation of the mevalonate pathway[J].Nature,1990,343 (6257):425-430.
  • 4Athyros VG,Kakafika AI,Tziomalos K,et al.Pleiotropic effects of statins-clinical evidence[J].Current Pharmaceutical Design,2009,15(5):479-489.
  • 5Florio T,Thellung S,Arena S,et al.Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitro[J].Eur J Endocrinol,1999,141(4):396-408.
  • 6Holstein SA,Hohl RJ.Interaction of cytosine arabinoside and lovastatin in human leukemia cells[J].Leukemia Res,2001,25(8):651-660.
  • 7Zuckerbraun BS,Shapiro RA,Billiar TR,et al.RhoA influences the nuclear localization of extracellular signal-regulated kinases to modulate p21Waf/Cipl expression[J].Circulation,2003,108 (7):876-881.
  • 8Xia Z,Tan MM,Wong WW,et al.Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells[J].Leukemia,2001,15 (9):1398-1407.
  • 9Chen WF, Deng SL. Curcumin and its analogues as potent inhibitors of low density 1 ipoprotein oxidation: H-atom ab- straction from the phenolic groups and possible involvement of the 4-hydroxy-3-methoxyphenyl groups [ J ]. Free Radic Biol Med, 2005, 9: 1-10.
  • 10Hansson GK. Inflammation, atherosclemsis, and coronary artery disease[J]. N Engl J Med, 2005, 352(1): 685- 695.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部